Recently, the globally renowned consulting firm Frost & Sullivan officially released the 2026 Global AI Healthcare Industry Development Blue Book, which systematically reviews the technological evolution, industry chain structure, application scenarios and long-term development trends of the global and Chinese AI healthcare sectors.

PA Gooddoctor, with its mature AI healthcare implementation system, its innovative "AI plus human doctors" service model and its full-scenario service ecosystem, was successfully selected as a key case, joining a number of leading AI healthcare companies as benchmark samples of the global AI healthcare industry chain, systematically demonstrating to the global industrial, investment and academic communities the innovative practices of Chinese enterprises in the AI healthcare field.

This authoritative inclusion marks that PA Gooddoctor's AI healthcare capabilities and service development have received professional recognition from a top international research institution.

Authoritative Endorsement: "AI Plus Human Doctors" Dual-Engine Model Highly Praised by the Blue Book

Founded in 1961, Frost & Sullivan has 65 years of global industry research accumulation and is a globally renowned growth consulting firm. Its research reports are known for their rigor, independence and forward-looking nature, and have long been regarded as an important reference for capital markets and industrial decision-making.

The Blue Book provides a systematic analysis of the current status and future trends of the global and Chinese AI healthcare industries, covering technological evolution, industry chain structure, application scenarios, market landscape, business models, regulatory policies, development challenges and future trends, offering decision-making references for medical institutions, AI healthcare companies, investment institutions and various industry participants, and serving as an important third-party research window for the global industrial community to observe the development of China's AI healthcare industry.

The Blue Book points out that AI healthcare "is no longer a single algorithmic tool, but a comprehensive capability composed of medical data, algorithm models, computing infrastructure, medical knowledge systems and clinical scenarios," and that its value is "extending from single-point efficiency improvement to medical resource optimization, clinical decision support, service process reconstruction and industrial collaboration."

PA Gooddoctor's exploration is precisely oriented around this direction.

The Blue Book highlights the real-world implementation results of PA Gooddoctor's AI healthcare and highly recognizes the company's development model that aligns with the industry's systematic, scenario-based and long-term development approach.

The Blue Book notes that after years of development, PA Gooddoctor has upgraded from an online medical service platform to an AI-driven healthcare service ecosystem platform, which "builds differentiated advantages through the 'AI plus human doctors' dual-engine model" and "constructs a 'human plus machine plus ecosystem' closed loop, promoting deep integration of AI technology with medical scenarios."

Aligned with the industry's core development logic, PA Gooddoctor becomes a sample of AI healthcare implementation. In recent years, PA Gooddoctor has continuously deepened the industrialization, specialization and refinement of AI healthcare around an integrated technology loop of "data plus model plus scenario."

At the model layer, the company has iteratively upgraded the Ping An MedGPT medical large model and improved five specialized vertical models for key scenarios. The Ping An Medical Large Model 3.5, jointly developed by Ping An Technology, PA Gooddoctor and Peking University Healthcare, achieved the highest global score of 57.27 in HealthBench Hard, a globally authoritative medical AI evaluation set, surpassing leading institutions such as Meta and OpenAI and setting a new record for that benchmark score.

Citing data, the Blue Book points out that as of the end of 2025, PA Gooddoctor's AI-assisted diagnosis and treatment accuracy rate exceeded 95%, triage accuracy exceeded 99%, AI doctors accurately diagnosed more than 11,300 diseases, and the annual number of AI doctor users approached 12 million.

At the application layer, the company has built AI plus human doctor serious medical services, established a service paradigm of "AI second-level response plus human doctor full-process supervision," and launched a "1 plus 6" AI health steward product matrix covering diverse needs from serious medical care to full-lifecycle health management.

At the scenario layer, the company has deeply connected AI technology with its "four-reach" service network—online, in-hospital, at-home and at-work—achieving deep integration of intelligent technology and medical services and providing users with professional, comprehensive and high-quality one-stop medical, health and elderly care solutions.

In 2026, the company launched the "Ping An Home Care" service brand, combining AI capabilities with digital health management tools to introduce a series of "7 Good" flagship services covering sleep, nutrition, exercise and other home scenarios around users' long-term health needs, driving health management from phased intervention to continuous monitoring, proactive intervention and full-cycle management, and achieving coordinated development of chronic disease management with home elderly care and long-term care.

In addition, relying on its self-developed DeepBody skeletal recognition engine, the company has created Ping An Smart Private Training, adopting a dual-teacher accompanying training model of AI intelligent coach plus human private trainer, and building a sports health loop of "assessment-training-consolidation" to complete home-based proactive health intervention capabilities.

For foreign nationals coming to China, the company has launched Ping An Cross-border Health, equipped with a medical AI real-time translation engine supporting 19 languages, building a cross-border medical loop of online consultation, specialist pick-up and full-process in-hospital accompaniment, further expanding the service boundaries of the "four-reach" network and meeting international health service needs.

As AI technology accelerates its integration with clinical scenarios, the focus of competition in AI healthcare has shifted from algorithmic metrics to commercial closed loops and service accessibility. Chinese enterprises represented by PA Gooddoctor are providing demonstration samples for the industrialization of global AI healthcare.

From technology research and development to systematic implementation, PA Gooddoctor's practices demonstrate the tangible value of AI technology in optimizing medical resource allocation, and will further advance the delivery of high-quality medical and health services toward greater efficiency, professionalism and broader coverage.